Giant Cell tumors (GCT) are benign tumors with potential for aggressive behavior and
capacity to metastasize. Although rarely lethal, benign bone tumors may be associated with …

Giant cell tumor (GCT) of bone is a benign but locally aggressive tumor that usually involves
the end of long bone. Its histogenesis remains unclear. It is characterized by a proliferation …

Background Giant-cell tumour (GCT) of bone is a primary osteolytic bone tumour with low
metastatic potential and is associated with substantial skeletal morbidity. GCT is rich in …

Background Many surgeons treat giant cell tumor of bone (GCT) with intralesional curettage.
Wide resection is reserved for extensive bone destruction where joint preservation is …

Background Two hundred and fourteen patients with benign giant cell tumor of bone
(GCTB), treated from 1980 to 2007 at the Department of Orthopedics of the University of …

Giant cell tumor (GCT) of bone is a locally aggressive benign neoplasm that is associated
with a large biological spectrum ranging from latent benign to highly recurrent and …

Sarcomas comprise a heterogeneous group of mesenchymal neoplasms. They can be
grouped into 2 general categories, soft tissue sarcoma and primary bone sarcoma, which …

Simple Summary According to the 2020 World Health Organization classification, a giant cell
tumor of bone is an intermediate malignant bone tumor. Denosumab treatment before …

The giant cell tumour of bone (GCT) is a locally aggressive intraosseous neoplasm of
obscure biological behaviour. Although well defined in clinical, radiological and histological …

Objective: To discuss the treatment and outcomes for giant cell tumor (GCT) of bone.
Materials and Methods: Review of the pertinent literature. Results: GCT is a rare benign …